Avid Bioservices Inc (CDMO)
12.30
+0.05
(+0.41%)
USD |
NASDAQ |
Nov 22, 16:00
12.29
-0.01
(-0.08%)
Pre-Market: 20:00
Avid Bioservices Cash from Financing (Quarterly): 0.266M for July 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 0.266M |
| April 30, 2024 | 11.83M |
| January 31, 2024 | 0.085M |
| October 31, 2023 | 7.40M |
| July 31, 2023 | 0.748M |
| April 30, 2023 | 0.704M |
| January 31, 2023 | 0.868M |
| October 31, 2022 | 0.40M |
| July 31, 2022 | 0.929M |
| April 30, 2022 | 0.163M |
| January 31, 2022 | 1.111M |
| October 31, 2021 | 1.005M |
| July 31, 2021 | 0.918M |
| April 30, 2021 | 85.31M |
| January 31, 2021 | 32.78M |
| October 31, 2020 | -0.462M |
| July 31, 2020 | -5.289M |
| April 30, 2020 | 3.315M |
| January 31, 2020 | -0.597M |
| October 31, 2019 | -0.721M |
| July 31, 2019 | -0.901M |
| April 30, 2019 | -0.847M |
| January 31, 2019 | -1.052M |
| October 31, 2018 | -0.823M |
| July 31, 2018 | -0.141M |
| Date | Value |
|---|---|
| April 30, 2018 | 20.87M |
| January 31, 2018 | -0.821M |
| October 31, 2017 | -0.865M |
| July 31, 2017 | 3.07M |
| April 30, 2017 | 17.99M |
| January 31, 2017 | 4.675M |
| October 31, 2016 | 4.416M |
| July 31, 2016 | 1.08M |
| April 30, 2016 | 0.867M |
| January 31, 2016 | 6.271M |
| October 31, 2015 | 25.70M |
| July 31, 2015 | 8.951M |
| April 30, 2015 | 19.95M |
| January 31, 2015 | 2.391M |
| October 31, 2014 | 3.392M |
| July 31, 2014 | 9.242M |
| April 30, 2014 | 21.58M |
| January 31, 2014 | 27.54M |
| October 31, 2013 | 9.172M |
| July 31, 2013 | 14.77M |
| April 30, 2013 | 13.68M |
| January 31, 2013 | 8.595M |
| October 31, 2012 | 15.15M |
| July 31, 2012 | 1.424M |
| April 30, 2012 | 7.11M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-5.289M
Minimum
Jul 2020
85.31M
Maximum
Apr 2021
7.446M
Average
0.868M
Median
Jan 2023
Cash from Financing (Quarterly) Benchmarks
| MEI Pharma Inc | -- |
| Altimmune Inc | 0.266M |
| Catalent Inc | -10.00M |
| NovaBay Pharmaceuticals Inc | 2.089M |
| Palatin Technologies Inc | -0.127M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.68M |
| Cash from Investing (Quarterly) | -1.311M |
| Free Cash Flow | -11.45M |
| Free Cash Flow Per Share (Quarterly) | -0.0784 |
| Free Cash Flow to Equity (Quarterly) | -5.265M |
| Free Cash Flow to Firm (Quarterly) | -2.537M |
| Free Cash Flow Yield | -1.47% |